Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹30915 Cr.
Stock P/E
47.9
P/B
4.1
Current Price
₹526
Book Value
₹ 129.1
Face Value
10
52W High
₹586.8
52W Low
₹ 413.2
Dividend Yield
0%

Star Health & Allied Overview

Business

Star Health and Allied Insurance Company Ltd. is a specialized health insurance provider in India. The company focuses exclusively on health, personal accident, and overseas travel insurance products. Its core business model involves underwriting various health insurance policies for individuals, families, and corporates. Star Health primarily generates revenue through collecting premiums from its policyholders and investing these premiums (investment income) before claims are paid out. It offers a wide range of products including medi-classic, star comprehensive, senior citizen red carpet, star cancer care, and various group health policies.

Revenue Mix

Star Health is almost entirely focused on health insurance, which forms the overwhelming majority of its gross written premiums. Within health insurance, it primarily caters to the retail segment (individuals and families), which is its largest contributor. It also has a significant presence in the group health insurance segment and offers personal accident and overseas travel insurance, though these are relatively smaller contributors to the overall premium mix. Its specialized focus means there are no distinct major non-health insurance segments.

Industry

The Indian insurance industry is undergoing rapid growth, driven by increasing awareness and disposable incomes. The health insurance segment is particularly competitive, with both public sector general insurers and private players (including standalone health insurers like Star Health) vying for market share. Star Health is a market leader in the retail health insurance segment in India, characterized by its specialized focus and extensive distribution network. It differentiates itself by offering a wide array of health-specific products and by focusing on in-house claims processing.

MOAT

Star Health possesses several durable advantages:

Specialization & Brand Recognition: Its singular focus on health insurance has allowed it to build a strong brand reputation and expertise in the segment, making it a recognized name for health insurance.

Extensive Agent Network: It boasts one of the largest and most widespread agency networks in the Indian health insurance space, especially in Tier 2 and Tier 3 cities, providing deep market penetration.

Proprietary Hospital Network & In-house Claims: A large network of empaneled hospitals and an in-house claims settlement process contribute to better cost control and potentially superior customer experience compared to third-party administrators.

Scale: As a leader in retail health, it benefits from economies of scale in underwriting, claims management, and distribution.

Growth Drivers

Under-penetration of Health Insurance: India has very low health insurance penetration compared to developed economies, presenting a large untapped market.

Rising Healthcare Costs: Increasing medical inflation and a greater prevalence of lifestyle diseases are driving the need for health insurance.

Growing Health Awareness: The COVID-19 pandemic significantly boosted health insurance awareness and adoption.

Digital Adoption: Increasing digitalization and online sales channels can expand reach and improve operational efficiency.

Increasing Disposable Income: Rising income levels are allowing more individuals and families to afford health insurance.

Government Initiatives: Schemes like Ayushman Bharat are increasing overall health awareness and setting a baseline for health coverage.

Risks

Intense Competition: The entry of new players and aggressive strategies by existing general insurers can lead to pricing pressure and market share erosion.

Medical Inflation: Higher-than-expected medical inflation can significantly impact claims costs and underwriting profitability.

Regulatory Changes: Changes in IRDAI (Insurance Regulatory and Development Authority of India) regulations regarding product pricing, solvency margins, or distribution can impact operations and profitability.

Adverse Claims Experience: A sudden increase in claims frequency or severity (e.g., due to pandemics or new diseases) can severely affect financial performance.

Agent Attrition: Reliance on a large agent network means high agent attrition could impact distribution capability.

Investment Market Volatility: As insurers invest policyholder funds, adverse movements in financial markets can impact investment income.

Management & Ownership

Star Health was initially promoted by Safecrop Investments Ltd. (a consortium led by Westbridge Capital and Madison India Capital) along with other private equity investors and individual founders. Post-IPO, the ownership is diversified with significant stakes held by institutional investors (both domestic and foreign) and public shareholders. The management team comprises experienced professionals from the insurance and financial services sectors, overseeing operations and strategic direction.

Outlook

Star Health is well-positioned to capitalize on the significant growth potential in the Indian health insurance market, driven by its specialized focus, strong brand, and extensive distribution network, particularly in the retail segment. The long-term trajectory for health insurance penetration in India remains positive. However, the company faces intense competition from general insurers and other standalone health insurers, along with the constant challenge of managing medical inflation and maintaining underwriting profitability. Its ability to innovate products, expand its reach efficiently, and control claims costs will be crucial for sustained market leadership and profitable growth amidst a dynamic regulatory and competitive landscape.

Star Health & Allied Share Price

Live · BSE / NSE · Inception: 2005
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Star Health & Allied Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 3294 3395 3520 3704 3800 3798 3938 4081 4250 4327
Other Income 285 296 297 357 348 290 296 300 318 325
Total Income 3579 3692 3817 4061 4148 4088 4234 4381 4568 4652
Total Expenditure 3191 3502 3391 3912 3861 4089 3882 4303 4395 4500
Operating Profit 388 190 426 149 287 -1 352 78 173 151
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 388 190 426 149 287 -1 352 78 173 151
Provision for Tax 98 47 107 38 72 -1 90 23 45 40
Profit After Tax 290 142 319 111 215 1 263 55 128 111
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 290 142 319 111 215 1 263 55 128 111
Adjusted Earnings Per Share 4.9 2.4 5.4 1.9 3.7 0 4.5 0.9 2.2 1.9

Star Health & Allied Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1018 1514 1911 2740 3662 4684 4627 9809 11262 12938 14822 16596
Other Income 42 63 62 89 115 170 251 480 501 642 772 1239
Total Income 1060 1577 1974 2828 3778 4854 4877 10289 11763 13580 15594 17835
Total Expenditure 1207 1329 1877 2690 3548 4523 6358 11871 11057 12849 15201 17080
Operating Profit -147 249 97 138 229 330 -1481 -1582 706 731 393 754
Interest 1 2 3 7 2 3 3 26 35 39 24 0
Depreciation 19 17 20 23 28 29 46 43 52 59 71 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -140 137 118 171 267 406 -1446 -1397 826 1129 861 754
Provision for Tax 0 0 0 1 84 143 -360 -356 208 284 215 198
Profit After Tax -140 137 118 170 183 263 -1086 -1041 619 845 646 557
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -140 137 118 170 183 263 -1086 -1041 619 845 646 557
Adjusted Earnings Per Share -3.9 3.5 2.6 3.7 4 5.4 -19.8 -18.1 10.6 14.4 11 9.5

Star Health & Allied Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 142 360 789 960 1493 1904 3500 4604 5434 6342 7024
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 250 250 250 250 720 470 470 470
Other Non-Current Liabilities 751 792 1190 1683 2158 2623 5187 6229 7292 8478 9170
Total Current Liabilities 210 238 278 537 914 1216 1564 1961 2030 2478 4121
Total Liabilities 1102 1390 2257 3430 4815 5994 10501 13514 15226 17768 20785
Fixed Assets 46 62 77 92 85 90 80 113 101 159 161
Other Non-Current Assets 514 810 1435 2169 3043 4309 7277 12154 13971 15866 18274
Total Current Assets 542 518 745 1169 1687 1595 3144 1247 1154 1744 2350
Total Assets 1102 1390 2257 3430 4815 5994 10501 13514 15226 17768 20785

Star Health & Allied Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 57 80 94 229 372 750 513 1599 378 288 445
Cash Flow from Operating Activities 147 126 321 557 776 647 890 56 1276 1310 1379
Cash Flow from Investing Activities -216 -192 -497 -663 -731 -1006 -2418 -3786 -1097 -1177 -1151
Cash Flow from Financing Activities 92 81 310 249 333 122 2613 2509 -268 23 -4
Net Cash Inflow / Outflow 24 14 134 143 379 -237 1086 -1221 -89 156 224
Closing Cash & Cash Equivalent 80 94 229 372 750 513 1599 378 288 445 668

Star Health & Allied Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 0 0 0 0 0 -19.81 -18.08 10.63 14.44 10.99
CEPS(Rs) -3.87 3.53 2.59 3.73 4.03 5.37 -19.81 -18.08 10.63 14.44 10.99
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0 0 0 0 0 0 63.85 78.68 93.35 108.31 119.46
Core EBITDA Margin(%) -18.6 12.23 1.78 1.81 3.11 3.43 -37.43 -21.02 1.82 0.69 -2.55
EBIT Margin(%) -13.76 9.02 6.17 6.25 7.29 8.67 -31.25 -14.24 7.34 8.72 5.81
Pre Tax Margin(%) -13.76 9.02 6.17 6.25 7.29 8.67 -31.25 -14.24 7.34 8.72 5.81
PAT Margin (%) -13.76 9.02 6.17 6.21 5.01 5.62 -23.47 -10.61 5.49 6.53 4.36
Cash Profit Margin (%) -13.76 9.02 6.17 6.21 5.01 5.62 -23.47 -10.61 5.49 6.53 4.36
ROA(%) -84.51 54.42 20.52 17.02 12.42 13.5 -36.81 -22.89 10.97 13.16 8.91
ROE(%) -84.51 54.42 20.52 19.46 17.45 17.28 -40.19 -25.93 12.42 14.36 9.67
ROCE(%) -84.51 54.42 20.52 17.13 20.52 22.91 -48.98 -31.04 14.83 17.76 12.04
Receivable days 0 0 0 0 0 0 0 0 0 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 0 0 0 0 0 0 0 0 48.76 37.62 32.42
Price/Book(x) 0 0 0 0 0 0 0 9.03 5.55 5.01 2.98
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.03 0.08 0.07 -0.02 -0.12 -0.03 -0.29 4.19 2.69 2.46 1.4
EV/Core EBITDA(x) -0.23 0.46 1.29 -0.34 -1.91 -0.37 0.9 -25.95 42.95 43.5 52.73
Net Sales Growth(%) 50.72 48.72 26.26 43.33 33.68 27.9 -1.23 112.02 14.81 14.89 14.56
EBIT Growth(%) -50.07 197.52 -13.64 45.16 56 52.09 -455.93 3.4 159.17 36.6 -23.72
PAT Growth(%) -50.07 197.52 -13.64 44.27 7.79 43.56 -512.34 4.15 159.44 36.6 -23.57
EPS Growth(%) 0 0 0 0 0 0 -469.12 8.72 158.81 35.76 -23.89
Debt/Equity(x) 0 0 0 0 0 0 0 0.16 0.09 0.07 0.07
Current Ratio(x) 0.56 0.5 0.51 0.53 0.54 0.42 0.47 0.15 0.12 0.16 0.18
Quick Ratio(x) 0.56 0.5 0.51 0.53 0.54 0.42 0.47 0.15 0.12 0.16 0.18
Interest Cover(x) 0 0 0 0 0 0 0 0 0 0 0
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.02 0.02 0.01 0.02

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +15% +15% +26% +31%
Operating Profit CAGR -46% +4%
PAT CAGR -24% +20%
Share Price CAGR +12% -1%
ROE Average +10% +12% -6% +1%
ROCE Average +12% +15% -7% +1%

Star Health & Allied Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 57.98 %
FII 15.05 %
DII (MF + Insurance) 20.3 %
Public (retail) 42.02 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 57.9457.9257.957.6957.6857.6758.0458.0257.9857.98
FII 3126.5721.5817.6517.5118.6813.913.514.0715.05
DII 6.1111.1415.1117.0516.4315.4321.0821.0920.9620.3
Public 42.0642.0842.142.3142.3242.3341.9641.9842.0242.02
Others 0000000000
Total 100100100100100100100100100100

Star Health & Allied Peer Comparison

Insurance Edit Columns

Star Health & Allied Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Star Health & Allied Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 12% over the last 3 years.
  • Stock is trading at 4.1 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp